Invus

Invus company information, Employees & Contact Information

Updated May 2026

Quick answer

Invus is a Venture Capital and Private Equity Principals company. It has approximately 87 employees on record. Contact data was last refreshed in May 2026. Find Invus's verified employee emails, phone numbers, headquarters address, and key decision makers below.

Explore related pages

Related company profiles:

Invus has been empowering entrepreneurs to transform their industries since 1985. We have a continuous capital structure with over $10 billion under management and offices in the U.S., Europe and Asia. We focus on investments in consumer, technology and life sciences. We know what it takes to transform an industry: strategic insight, capital that isn't on an arbitrary exit schedule and world-class execution. We partner with entrepreneurs and their teams on all three of these dimensions. Invus offers the best of both worlds: The time horizon and personal attention of a bespoke family office with the professionalism and capabilities of a world-class multi-strategy firm. In addition to investing in private companies, we have been investing in public companies since 2004, where we take significant, long-term positions. We have been running a fund-of-funds strategy since 1994 with a particular expertise and focus in emergin/early-stage hedge fund managers. We welcome you to visit our website and learn more about Invus.

Company Details

Employees
87
Address
750 Lexington Ave, 30th Floor,france
Email
NY****@****vus.com
Industry
Venture Capital And Private Equity Principals
NAICS
Miscellaneous Intermediation
Website
invus.com
HQ
New York, NY
Looking for a particular Invus employee's phone or email?

Invus Questions

News

SeoulSpice expands to Chicago after Invus investment - Restaurant Hospitality

SeoulSpice expands to Chicago after Invus investment Restaurant Hospitality

Coave Therapeutics Secures €32 Million ($33 Million) in Series A Financing to Advance its Next-Generation Genetic Medicines - GlobeNewswire

Coave Therapeutics Secures €32 Million ($33 Million) in Series A Financing to Advance its Next-Generation Genetic Medicines GlobeNewswire

D.C.-based fast-casual chain SeoulSpice is opening 3 restaurants in Chicago - Crain's Chicago Business

D.C.-based fast-casual chain SeoulSpice is opening 3 restaurants in Chicago Crain's Chicago Business

Call Your Mother wins significant strategic investment for expansion - Restaurant Business Magazine

Call Your Mother wins significant strategic investment for expansion Restaurant Business Magazine

Aive Raises €12M in Series A Funding - FinSMEs

Aive Raises €12M in Series A Funding FinSMEs

Call Your Mother Deli Teams Up With Invus Group - Finimize

Call Your Mother Deli Teams Up With Invus Group Finimize

Stanford University and The Invus Group collaborate to develop glioblastoma drugs - Stanford Medicine

Stanford University and The Invus Group collaborate to develop glioblastoma drugs Stanford Medicine

Call Your Mother receives investment from private equity firm behind CAVA’s growth - Restaurant Hospitality

Call Your Mother receives investment from private equity firm behind CAVA’s growth Restaurant Hospitality

Data Science and AI Company KNIME Secures Investment to Accelerate Adoption of Enterprise-Grade AI Governance and ModelOps - Business Wire

Data Science and AI Company KNIME Secures Investment to Accelerate Adoption of Enterprise-Grade AI Governance and ModelOps Business Wire

Health Data Analytics Institute (HDAI) Announces $31 Million Funding Round to Scale Predictive Risk Platform - PR Newswire

Health Data Analytics Institute (HDAI) Announces $31 Million Funding Round to Scale Predictive Risk Platform PR Newswire

Open-source data science platform Knime raises $30M to seize opportunity in generative AI - SiliconANGLE

Open-source data science platform Knime raises $30M to seize opportunity in generative AI SiliconANGLE

Agomab Announces $89 Million Series D Financing to Support Broad Fibrosis-Focused Pipeline - BioSpace

Agomab Announces $89 Million Series D Financing to Support Broad Fibrosis-Focused Pipeline BioSpace

This investor made billions on Weight Watchers over 23 years and got out just before the stock imploded - MarketWatch

This investor made billions on Weight Watchers over 23 years and got out just before the stock imploded MarketWatch

Hashtag You: received growth equity from Tengelmann Ventures and Invus - Carlsquare Corporate Finance

Hashtag You: received growth equity from Tengelmann Ventures and Invus Carlsquare Corporate Finance

BelliWelli secures funding for retail and team expansion - Ingredients Network

BelliWelli secures funding for retail and team expansion Ingredients Network

Ashley Stewart Acquired by The Invus Group from Clearlake Capital Group and FirePine Group - PRWeb

Ashley Stewart Acquired by The Invus Group from Clearlake Capital Group and FirePine Group PRWeb

Booster Fuels raises $56M in funding from Invus Opportunities - The Business Press

Booster Fuels raises $56M in funding from Invus Opportunities The Business Press

The Invus Group Congratulates CAVA on NYSE IPO - PR Newswire

The Invus Group Congratulates CAVA on NYSE IPO PR Newswire

ClearScore Secures $200m investment from Invus Opportunities - Business Wire

ClearScore Secures $200m investment from Invus Opportunities Business Wire

Providence Agrees to Acquire Airties - PR Newswire

Providence Agrees to Acquire Airties PR Newswire

ClearScore lands $200m investment from Invus - FinTech Futures

ClearScore lands $200m investment from Invus FinTech Futures

Clearlake to make 5-6x its money with Ashley Stewart sale to Invus Group - pehub.com

Clearlake to make 5-6x its money with Ashley Stewart sale to Invus Group pehub.com

SeoulSpice begins national expansion with big-name investment - The Business Journals

SeoulSpice begins national expansion with big-name investment The Business Journals

Bambusa Therapeutics Raises Approximately $90 Million in Series A Financing to Advance Next-generation Bispecific Antibodies for Immunology & Inflammation Diseases - BioSpace

Bambusa Therapeutics Raises Approximately $90 Million in Series A Financing to Advance Next-generation Bispecific Antibodies for Immunology & Inflammation Diseases BioSpace

Noema Pharma raises CHF54 million in Series A financing round led by Sofinnova Partners and Polaris Partners - GlobeNewswire

Noema Pharma raises CHF54 million in Series A financing round led by Sofinnova Partners and Polaris Partners GlobeNewswire

Ashley Stewart confirms Invus backing - FashionNetwork USA

Ashley Stewart confirms Invus backing FashionNetwork USA

Investment firm acquires plus-size retailer Ashley Stewart - The Business Journals

Investment firm acquires plus-size retailer Ashley Stewart The Business Journals

Jumbotail raises $85 mn from Invus affiliate, others; Kalaari exits partially - Mint

Jumbotail raises $85 mn from Invus affiliate, others; Kalaari exits partially Mint

UK fintech Clearscore on path to unicorn valuation with Invus deal - Sky News

UK fintech Clearscore on path to unicorn valuation with Invus deal Sky News

Rapido enters unicorn club with $200 mn fundraise led by WestBridge Capital - Mint

Rapido enters unicorn club with $200 mn fundraise led by WestBridge Capital Mint

Jumbotail to raise money at unicorn valuation as it acquires Solv - The Morning Context

Jumbotail to raise money at unicorn valuation as it acquires Solv The Morning Context

Top Invus Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant